# TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

> **NCT07454486** · — · NOT_YET_RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Biliary Tract Cancer (BTC)
- Biliary Tract Cancer (CCA)
- Gall Bladder Cancer
- Biliary Tract Cancers (BTC)
- Cholangiocarcinoma
- Cholangiocarcinoma Non-resectable
- Cholangiocarcinoma Resectable
- Cholangiocarcinoma Metastatic
- Cholangiocarcinoma of the Bile Duct
- Cholangiocarcinoma, Extrahepatic
- Cholangiocarcinoma, Hilar
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinoma, Perihilar
- Cholangiocarcinoma; Liver

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07454486
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2030-12-30
- **Final completion:** 2031-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07454486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07454486, "TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT07454486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*